Literature DB >> 375966

Radiosensitization of E. coli B/r by the cytotoxic agent procarbazine: a hypoxic cell sensitizer preferentially toxic to aerobic cells and easily oxidized.

P B Roberts.   

Abstract

Procarbazine has been shown to be a hypoxic cell sensitizer of moderate ability in E. coli B/r, with an achievable enhancement ratio of 1.4 at subtoxic concentrations. The drug appears to act in a manner similar to the expected with the electron-affinic radiosensitizers. However, procarbazine and the electron-affinic sensitizers differ in two important respects. Unlike the electron-affinic sensitizers, procarbazine is not easily reduced, but is easily oxidized. It is more toxic to aerobic than to hypoxic cells. At the drug dosages in present clinical use, procarbazine is likely to be only a weak radiosensitizer. The possible implications of the data for the further development of a new class of sensitizers and combination therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375966      PMCID: PMC2009976          DOI: 10.1038/bjc.1979.129

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  HYDRATED ELECTRONS AND RADIOBIOLOGICAL SENSITISATION.

Authors:  G E ADAMS; D L DEWEY
Journal:  Biochem Biophys Res Commun       Date:  1963-08-20       Impact factor: 3.575

2.  Rulse radiolysis and ESR studies of the electron-affinic properties of nitroheterocyclic radiosensitizers.

Authors:  C L Greenstock; G W Ruddock; P Neta
Journal:  Radiat Res       Date:  1976-06       Impact factor: 2.841

3.  A randomized study comparing irradiation alone to irradiation plus procarbazine in inoperable bronchogenic carcinoma.

Authors:  R C Landgren; D H Hussey; M L Samuels; W V Leary
Journal:  Radiology       Date:  1973-08       Impact factor: 11.105

Review 4.  Drugs 5 years later: procarbazine.

Authors:  S D Spivack
Journal:  Ann Intern Med       Date:  1974-12       Impact factor: 25.391

5.  Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria.

Authors:  G E Adams; M S Cooke
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1969-07

6.  Chemical sensitization of mice to radiation lethality.

Authors:  H Moroson; H A Spielman
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1966

7.  Radiation and high-dose metronidazole in supratentorial glioblastomas.

Authors:  R Urtasun; P Band; J D Chapman; M L Feldstein; B Mielke; C Fryer
Journal:  N Engl J Med       Date:  1976-06-17       Impact factor: 91.245

8.  Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.

Authors:  R H Thomlinson; S Dische; A J Gray; L M Errington
Journal:  Clin Radiol       Date:  1976-04       Impact factor: 2.350

9.  Mammalian cell toxicity of nitro compounds : dependence upon reduction potential.

Authors:  G E Adams; E D Clarke; R S Jacobs; I J Stratford; R G Wallace; P Wardman; M E Watts
Journal:  Biochem Biophys Res Commun       Date:  1976-10-04       Impact factor: 3.575

10.  Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitro.

Authors:  I J Stratford; G E Adams
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

View more
  1 in total

Review 1.  The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.

Authors:  Niklas Benedikt Pepper; Walter Stummer; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2022-05-03       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.